Circuit Clinical/Crystal Run Healthcare LLP

Middletown, New York 10941

0 studies enrolling now · 2 studies all time

What they study most

Covid19, Metastatic Castrate Resistant Prostate Cancer (mCRPC), Post-acute COVID-19 Respiratory Disease

Studies at this site

• LYT-100 in Post-acute COVID-19 Respiratory Disease — Stopped early
• A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). — Running, not enrolling